Insight Molecular Diagnostics (IMDX) Invested Capital: 2020-2025
Historic Invested Capital for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to -$8.1 million.
- Insight Molecular Diagnostics' Invested Capital fell 178.84% to -$8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.1 million, marking a year-over-year decrease of 178.84%. This contributed to the annual value of -$12.0 million for FY2024, which is 152.88% down from last year.
- According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Invested Capital is -$8.1 million, which was down 555.51% from $1.8 million recorded in Q2 2025.
- In the past 5 years, Insight Molecular Diagnostics' Invested Capital ranged from a high of $114.4 million in Q2 2021 and a low of -$12.0 million during Q4 2024.
- In the last 3 years, Insight Molecular Diagnostics' Invested Capital had a median value of $11.1 million in 2024 and averaged $14.1 million.
- Per our database at Business Quant, Insight Molecular Diagnostics' Invested Capital soared by 186.47% in 2021 and then slumped by 178.84% in 2025.
- Over the past 5 years, Insight Molecular Diagnostics' Invested Capital (Quarterly) stood at $66.6 million in 2021, then tumbled by 48.35% to $34.4 million in 2022, then tumbled by 33.78% to $22.8 million in 2023, then slumped by 152.88% to -$12.0 million in 2024, then plummeted by 178.84% to -$8.1 million in 2025.
- Its Invested Capital was -$8.1 million in Q3 2025, compared to $1.8 million in Q2 2025 and $10.7 million in Q1 2025.